CHICAGO, ILL., and WASHINGTON, D.C. – December 1, 2022 – Sheridan Capital Partners, a prominent Chicago-based private equity firm, has announced a strategic investment in ADVI Health, a leading healthcare consultancy. This partnership marks a significant step for both firms, aiming to accelerate ADVI Health’s growth and expand its impact in the evolving healthcare landscape. Sheridan Capital Partners’ investment underscores its commitment to supporting innovative healthcare service companies and fostering growth within the sector.
ADVI Health, known for its expertise in solving complex healthcare challenges, will leverage Sheridan Capital Partners’ resources and healthcare focus to enhance its market position. The collaboration is set to amplify ADVI’s capabilities in market access, commercialization, and policy, enabling the consultancy to broaden its service offerings and reach a wider client base. Senior leaders at ADVI Health will maintain a substantial ownership stake and continue to lead the company’s operations, ensuring continuity and leveraging their deep industry knowledge.
Marc Samuels, Founder and CEO of ADVI Health, expressed enthusiasm about the partnership, stating, “Partnering with Sheridan Capital Partners is a pivotal moment for ADVI. Their deep healthcare investment expertise and focus will be instrumental in our next phase of growth. This collaboration will allow us to invest further in our team, expand our solutions and products, and ultimately collaborate more effectively with innovators across the healthcare spectrum.” This strategic alliance with Sheridan Capital Partners is expected to significantly bolster ADVI’s ability to serve medical innovators, life science and digital therapy manufacturers, providers, and advocates globally.
Sheridan Capital Partners’ decision to invest in ADVI Health reflects their long-standing interest in the pharma services sector. Nicholas Rowland, Partner at Sheridan Capital Partners, highlighted the strategic rationale behind the investment: “ADVI Health stands out as a leader in providing data-informed insights crucial for navigating today’s complex healthcare environment. As novel therapeutics and innovative technologies rapidly enter the market, ADVI’s expertise becomes increasingly vital. We are excited to support ADVI’s platform and growth trajectory to help organizations worldwide adapt to policy, regulatory, and reimbursement changes.”
Sean Dempsey, also a Partner at Sheridan Capital Partners, further emphasized the firm’s commitment to ADVI’s mission: “For a decade, ADVI Health has been a trusted advisor, guiding clients through critical commercialization challenges. Sheridan Capital Partners is dedicated to supporting their continued success and enabling them to expand their reach and impact within the healthcare industry.” This partnership signals Sheridan Capital Partners’ confidence in ADVI Health’s business model and its potential for continued growth and leadership in the healthcare consulting space.
About Sheridan Capital Partners
Sheridan Capital Partners is a Chicago-based private equity firm specializing in the healthcare sector. With a focus on the lower middle market, Sheridan Capital Partners invests in buyouts and growth equity opportunities across the U.S. and Canada. The firm’s investment strategy targets companies within providers and provider services, healthcare IT and outsourced services, and consumer health and medical products. Sheridan Capital Partners is known for bringing strategic resources and expertise to its portfolio companies, aiming to accelerate growth, build sustainable value, and achieve strong investment outcomes. Their partnership with ADVI Health is a testament to their ongoing commitment to investing in and growing impactful healthcare businesses.
About ADVI Health
ADVI Health is a consultancy dedicated to solving intricate healthcare problems through data-driven commercialization, market access, and policy expertise. The firm comprises seasoned industry professionals with backgrounds in policy, payer dynamics, and life sciences. ADVI Health provides strategic guidance to health and science innovators globally, supporting them from early-stage diligence and discovery through to successful commercialization. ADVI Health’s proactive approach focuses on identifying opportunities to improve market access and reimbursement strategies, accelerating revenue generation and overall growth for its clients. The company’s proprietary Strategic Analytics and Value Economics (SAVEs) data set offers clients unparalleled competitive intelligence, encompassing data from a vast network of payers and covering over 200 million lives.
Financial and Legal Advisors
Clearsight Advisors, Inc. acted as the exclusive financial advisor to ADVI Health in this transaction, while Greenberg Traurig served as their legal counsel. McDermott Will & Emery LLP provided legal counsel to Sheridan Capital Partners. Debt financing for the transaction was provided by Twin Brook Capital Partners. The financial details of the investment remain undisclosed.
